Advanced Radiation Therapy (ART), manufacturer of the AccuBoost System for radiation therapy of partial breast and Elekta a global leader in cancer management systems and software, announced today that they have executed an agreement whereby ART acquires the assets of all AccuBoost installations held by Elekta, its worldwide distribution partner. As part of the transaction, ART has purchased the assets and the operating agreements for more than 20 installations in the U.S. The transaction is designed to enable both companies to focus on their core competencies, and serves AccuBoost user groups by allowing ART to increase its support to these installations.

Viztek, the advanced digital imaging solution provider, has received United States Federal Food and Drug Administration (FDA) 510k clearance for the ViZion + DR line of panels. This new family of products includes multiple panels in tethered, wireless and fixed configurations offering high quality images at quick speeds, while remaining at a competitive price point. Unlike many competing products, the panels have an ease of adaptability and require no generator interface.

Embrace Thermoplastic is a premium low-melt material used to create customizable immobilization for patients receiving radiation therapy treatments of the head and neck. Embrace Thermoplastic products include Standard UFrames, Versaboard frames, S-Type frames, and Thermoplastic sheets. All Embrace Thermoplastic products are made in the United States.

U.S. Imaging Equipment Servicing Market Millenium Market Research Group

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the U.S. market for diagnostic imaging equipment servicing will grow slowly to a value of just over $2.78 billion by 2017. Increases in diagnostic imaging system sales and the installed base will be counterbal
Hologic Inc. Radiology RSNA 3-D Mammography Clinical Study

http://glossary.itnonline.com/3d-mammographyHologic Inc. announced that a groundbreaking new study published in Radiology, the Radiological Society of North America scientific journal, found that the addition of three dimensional (3-D) mammography (breast tomosynthesis) screening technology to a 2-D breast screening exam significantly increased cancer detection while reducing the number of false positives.

January 11, 2013 — New guidelines from the American Cancer Society say there is now sufficient evidence to recommend screening high-risk patients for lung cancer with low-dose computed tomography (LDCT), provided that certain conditions exist.

Availability of CT colonography (CTC), commonly known as virtual colonoscopy, is increasing colorectal cancer (CRC) screening rates across military medical facilities. Inclusion of CTC as a Healthcare Effectiveness Data and Information Set (HEDIS)-compliant colorectal cancer (CRC) screening test can potentially raise overall screening rates, according to a study in the January issue of the Journal of the American College of Radiology.

In the management of gliomas — or tumors that originate in the brain — precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival. Research published in the December issue of The Journal of Nuclear Medicine (JNM) highlights the potential of imaging with 3'-deoxy-3'-F-18-fluorothymidine (F-18-FLT) positron emission tomography (PET) to noninvasively and accurately provide tumor-specific details to guide management of patients with gliomas.

breast imaging

According to a new market research report "Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) Technology and Market Analysis & Global Forecasts to 2017" is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now